about
Cochlear implantation updates: the Dallas Cochlear Implant Program.Assessment of cochlear implant candidacy in patients with cochlear nerve deficiency using the P1 CAEP biomarker.Speech recognition by bilateral cochlear implant users in a cocktail-party setting.Central auditory development: evidence from CAEP measurements in children fit with cochlear implants.Safety review of benzalkonium chloride used as a preservative in intranasal solutions: an overview of conflicting data and opinions.Biofilm presence in humans with chronic suppurative otitis media.Extracts from The Cochrane Library: Scopolamine (hyoscine) for preventing and treating motion sickness.Open-cavity tympanomastoidectomy.The children speak: an examination of the quality of life of pediatric cochlear implant usersParent versus child assessment of quality of life in children using cochlear implants.Pontine tegmental cap dysplasia: the neurotologic perspective.The Otology Data Collection project: report from the CHEER networkCochlear implant soft failures consensus development conference statement.Clinical practice guideline: cerumen impaction.Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults.Stereotactic radiosurgery of acoustic tumors.Meningitis following cochlear implantation: pathomechanisms, clinical symptoms, conservative and surgical treatments.Consensus panel on role of potentially ototoxic antibiotics for topical middle ear use: Introduction, methodology, and recommendations.Animal ototoxicity of topical antibiotics and the relevance to clinical treatment of human subjects.Comparative efficacy of aminoglycoside versus fluoroquinolone topical antibiotic drops.Clinical results with the Med-El compressed and split arrays in the United States.Histopathological basis of hearing impairment in Wolf-Hirschhorn syndrome.Management of pseudomeningocele following neurotologic procedures.Prevalence of gastroesophagopharyngeal acid reflux events: an evidence-based systematic review.Spectrum of middle and inner ear abnormalities in infants with congenital heart defects.Bacterial biofilm formation on a human cochlear implant.Optimal duration of allergic rhinitis clinical trials.Lesions of the petrous apex: diagnosis and management.Cortical maturation and behavioral outcomes in children with auditory neuropathy spectrum disorder.The link between allergic rhinitis and chronic otitis media with effusion in atopic patients.Management of spontaneous cerebrospinal fluid otorrhea.CT venography: use in selecting a surgical approach for the treatment of petrous apex cholesterol granulomas.Labyrinthitis ossificans: how accurate is MRI in predicting cochlear obstruction?Olopatadine nasal spray for the treatment of seasonal allergic rhinitis in patients aged 6 years and older.Cochlear implantation in children with enlarged vestibular aqueduct.Patterns of regional metastasis in advanced stage cutaneous squamous cell carcinoma of the auricle.Cochlear implantation in children with cochlear nerve absence or deficiency.Lumbar subarachnoid drainage in cerebrospinal fluid leaks after lateral skull base surgery.Olopatadine nasal spray for the treatment of allergic rhinitis.A comparison of ciprofloxacin/dexamethasone with neomycin/polymyxin/hydrocortisone for otitis externa pain.
P50
Q30416770-E608074B-0A28-44E8-9F78-4BEF62220668Q30451672-368F06A2-A3A6-469F-993F-B32E8C02C6CFQ30489824-026986E4-36FD-4703-AA70-FE11458287F5Q30490670-8C30F158-141E-480F-9AD8-80B6171BCC18Q30887604-E3C308F7-F075-462C-AFD8-B184B8898FB7Q33513041-D19751A2-EB79-4B85-90F6-97295725DBBEQ33543570-5865C94C-97D4-464D-8984-D36D21663A05Q33679346-AC429590-966C-4D8C-B8B7-6FA68BC24EB8Q33779564-BC41B636-1C25-4F76-879E-7D36674C41D7Q33937786-70139077-7E39-4708-84BA-4D7F2303F55FQ33943285-E67E3DCC-929F-4E6D-AAAB-A46EE6B2D1C2Q33965759-B181D9CC-C4FA-4945-A1D7-BB0194C76893Q34433698-0F5FCFB6-8C81-4043-8C14-126385552574Q34595625-178F2947-0C57-4A6E-AF48-750249BBEDE5Q34604845-3258F4F1-DD51-4D69-8D40-E7FAF58BF5AFQ34976323-AA841A04-F3EC-4EC0-91E6-2991CF8C9EE2Q35033623-448C50B8-5D5A-43C7-A75C-DF34DC954924Q35726252-CBDCD787-AB44-409F-9834-CDF4422B325CQ35726261-01297BD4-EE6A-4733-B780-E685C2439D28Q35726282-7ACD7874-5566-4337-9141-3B8B1AA3519DQ35748705-ED133407-0B9A-46B1-89B6-865F4A628052Q35849057-23E256F7-8EEE-4516-917C-7ED79B1CC72AQ35886553-F01202CA-E602-45C0-8CC2-C38CE23B7FEAQ36180729-47EDD26F-C925-47B2-A738-FD1181B07128Q36222308-D7D5BE38-7D66-4954-B89C-321F66864070Q36252967-544856F0-DA43-4705-9DFB-26F257A92F33Q36281063-45580A37-27B5-4F78-8D12-5202F377F634Q36838352-B03C2810-823D-4912-A72D-5367F0CE6FA7Q37075070-0B30D144-6C0A-43CE-971E-D8092C491635Q37105010-AA907EEA-7339-4782-89CD-66F22D3D970BQ37333541-7FC0C820-66CD-4F38-B2E1-6AC7ED52EA67Q37422922-6BBF7304-C84F-4A6E-B70D-DF2449871657Q37459361-288E6FEC-CC13-4798-80CC-76E27BA8BBC7Q37756143-87EC2FA9-6EF3-4718-8D40-601B82A8A323Q37773867-619B46D1-5319-41FC-8F49-F59E7CC615E9Q37865247-E7B7FB3F-CA36-41C7-B4DE-0E26FDBE0175Q37887476-6AB5F840-38CC-482E-B17D-58718CE3145CQ37940315-1B71D881-A615-4C75-8AFC-40D9E73C8307Q39287465-6B21B4AA-D989-4299-A7C2-C3FD4206B958Q39332491-72896AA2-814E-427E-9B6A-E32892069B62
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Peter S. Roland
@ast
Peter S. Roland
@en
Peter S. Roland
@es
Peter S. Roland
@nl
Peter S. Roland
@sl
type
label
Peter S. Roland
@ast
Peter S. Roland
@en
Peter S. Roland
@es
Peter S. Roland
@nl
Peter S. Roland
@sl
prefLabel
Peter S. Roland
@ast
Peter S. Roland
@en
Peter S. Roland
@es
Peter S. Roland
@nl
Peter S. Roland
@sl
P214
P244
P106
P1153
7102379787
P21
P213
0000 0000 4617 7531
P214
P244
P31
P496
0000-0003-4152-7346
P734
P735
P7859
lccn-n96802248